Intravenous nalbuphine for prevention of intrathecal morphine-induced nausea and vomiting in post caesarean section
Background Postoperative nausea vomiting (PONV) is quite common among patients who underwent cesarean section under spinal anesthesia with intrathecal morphine (ITMO). Nalbuphine is a mu receptor antagonist and kappa receptor agonist, which may mitigate opioid-related side effects. We hypothesized that intravenous (IV)...